SERUM GAMMA-GLUTAMYL TRANSFERASE AS A BIOMARKER OF TYPE-2 DM AMONG CIGARETTE SMOKERS

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2017, Vol 4, Issue 27

Abstract

BACKGROUND Smoking is one of the most common addictions of modern times and needs to be studied in a community as a public health issue. Also, smoking is a modifiable risk factor for type-2 DM. The smoking-related diseases share common pathophysiologies of imbalance of systemic oxidants and antioxidant status, increased inflammatory reactions, insulin resistance and dyslipidaemia. Biochemical assay of serum Gamma-Glutamyl Transferase (GGT) activity is a low cost and highly sensitive laboratory test. Studies have indicated GGT is moderately elevated before the onset of other traditional risk factors for type-2 DM. So, among hepatic markers, the baseline GGT analysis can be an early risk marker of type 2 diabetes in cigarette smokers has to be studied. MATERIALS AND METHODS This is a case-control study on male cigarette smokers. 57 smokers were studied clinically and biochemically for plasma insulin, glucose and liver enzymes including GGT using standard biochemical methods and compared with 42 age and sex matched non-smokers as controls. RESULTS The mean serum GGT in smokers (25.45 ± 10.8) was increased compared to non-smokers (18.8 ± 5.8). Smokers GGT (r=0.396) and HOMA-IR (r=0.352) showed significant positive association with duration of smoking (p<0.05) than fasting blood glucose. Multiple regression analysis showed only duration of smoking (p=0.001) as a dependable factor on GGT. 24.5% (14/57) smokers showed an increased GGT >24 IU/L. Regression analysis showed none of the diabetic risk factors were observed to be dependent on GGT including other liver enzymes. Regression analysis showed GGT is not an independent risk factor for DM. Although, the mean fasting blood glucose (91.4 ± 21.3), BMI (26.1 ± 9.3) and HOMA-IR (7.3 ± 2.3) was increased among cigarette smokers with GGT >24 IU/L. CONCLUSION The baseline GGT assay in cigarette smokers might be associated with the proinflammatory status or be a marker of oxidative stress of smoke toxins. Smokers with baseline GGT >24 IU/L develop insulin resistance should be investigated in future longitudinal studies for prediabetes to consider cigarette smoking as an important modifiable risk factor of type-2 DM.

Authors and Affiliations

Suganthy K, Mohanty P. K

Keywords

Related Articles

A CLINICAL APPROACH TO DIABETIC PERIPHERAL NEUROPATHY

Diabetes mellitus is characterized by increased blood sugars, which can lead to multiple macrovascular and microvascular problem. It is also a known cause of debilitating problem like peripheral neuropathy (PN). This rev...

A CASE OF LYMPHADENOPATHY- KIKUCHI WITH SLE

PRESENTATION OF CASE Kikuchi disease is a rare form of necrotising lymphadenopathy which has been associated with many autoimmune diseases. We are reporting the case of a 40- year-old female patient who presented with ly...

CHANGING NATURE OF AERODIGESTIVE FOREIGN BODIES IN A TERTIARY CARE CENTRE OF WEST BENGAL

BACKGROUND Foreign bodies in the aerodigestive tract are a common emergency faced by every ENT surgeon in day to day practice. The aim of the study is to observe the changing trend in the nature of distribution of differ...

USE OF PLATELET-RICH PLASMA INJECTION FOR THE TREATMENT OF CHRONIC PLANTAR FASCITIS

Plantar fascitis is a common cause of heel pain and different treatment options exists. PRP (platelet rich plasma) derived from autologous blood containing high concentration of growth factors help in tissue healing. The...

SEARCH TO FIND OUT CAUSE OF COMPLICATIONS OF DIABETIC PATIENT WHO WENT ON VENTILATOR AFTER OPEN CHOLECYSTECTOMY

Diabetes is very common now-a-days. Incidences of diabetes are increasing day by day. If not managed properly it is a slow killing disease. Its detrimental effects on various organs are not revealed clinically during ini...

Download PDF file
  • EP ID EP217734
  • DOI 10.18410/jebmh/2017/312
  • Views 76
  • Downloads 0

How To Cite

Suganthy K, Mohanty P. K (2017). SERUM GAMMA-GLUTAMYL TRANSFERASE AS A BIOMARKER OF TYPE-2 DM AMONG CIGARETTE SMOKERS. Journal of Evidence Based Medicine and Healthcare, 4(27), 1599-1603. https://europub.co.uk/articles/-A-217734